Trial of Intravenous Antiviral PF-07304814 in Hospitalized COVID-19 Patients Ends Early
A randomized clinical trial evaluating the intravenous SARS-CoV-2 protease inhibitor PF-07304814 in hospitalized COVID-19 patients closed prematurely following serious adverse ...




















